Category IV indications for therapeutic apheresis - ASFA fourth special issue

Journal of Clinical Apheresis

Volumn 22, Issue 3, 2007, Pages 176-180

  Shaz, Beth H ^a   Linenberger, Michael L ^b   Bandarenko, Nicholas ^c   Winters, Jeffrey L ^d   Kim, Haewon C ^e   Marques, Marisa B ^f   Sarode, Ravindra ^g   Schwartz, Joseph ^h   Weinstein, Robert ⁱ   Wirk, Ashka ^j   Szczepiorkowski, Zbigniew M ^k  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SEATTLE CANCER CARE ALLIANCE   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^d MAYO CLINIC   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h NewYork Presbyterian Hospital   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^j Malachite Management   (Canada)

^k DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

more..

Author keywords

Apheresis; Categories; Immunoadsorption; Leukocytapheresis; Photopheresis; Plasma exchange

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PENICILLAMINE; PREDNISONE;

AMYLOIDOSIS; AMYOTROPHIC LATERAL SCLEROSIS; APHERESIS; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CUTANEOUS T CELL LYMPHOMA; CYTAPHERESIS; DERMATOMYOSITIS; ERYTHROCYTE TRANSFUSION; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCLUSION BODY MYOSITIS; INFANTILE DIARRHEA; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LEUKAPHERESIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL SOCIETY; MONOTHERAPY; MUSCLE BIOPSY; MYOSITIS; PARAPROTEINEMIA; PLASMA TRANSFUSION; PLASMAPHERESIS; POLYMYOSITIS; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SCLERODERMA; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; DISEASE; HUMANS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL; UNITED STATES;

EID: 34347398426     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20131     Document Type: Review

References (35)

1. Klein HG, Balow JE, Dau PC, Hamburger MI, Leitman SF, Pineda AA, Tindall RS. Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for Apheresis. J Clin Apher 1986;3:i-vi,1-92.
2. McLeod BC. Introduction to the third special issue: clinical applications of therapeutic apheresis. J Clin Apher 2000;15:1-5.
3. Strauss RG, Ciavarella D, Gilcher RO, Kasprisin DO, Kiprov DD, Klein HG, McLeod BC. An overview of current management. J Clin Apher 1993;8:189-194.
4. Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Shaz BH, Weinstein R, Wirk A, Winters JL. Guidelines on the use of therapeutic apheresis in clinical practice - evidence based approach from the Clinical Applications committee of the American Society for Apheresis. J Clin Apher 2007;22:106-175.
5. Szczepiorkowski ZM, Shaz BH, Bandarenko N, Winters JL. The new approach to assignment of the ASFA categories - introduction to the fourth special issue: clinical applications of therapeutic apheresis. J Clin Apher 2007;22:96-105.
6. Siami GA, Siami FS. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenstrom's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis. Ther Apher 1999;3:8-19.
7. Drew MJ. Plasmapheresis in the dysproteinemias. Ther Apher 2002;6:45-52.
8. Mahmood A, Sodano D, Dash A, Weinstein R. Therapeutic plasma exchange performed in tandem with hemodialysis for patients with M-protein disorders. J Clin Apher 2006;21:100-104.
9. Kelemen J, Hedlund W, Orlin JB, Berkman EM, Munsat TL. Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis. Arch Neurol 1983;40:752-753.
10. Monstad I, Dale I, Pedund CF, Sjaastad O. Plasma exchange in motor neuron disease. A controlled study. J Neurol 1979;221:59-66.
11. Silani V, Scarlato G, Valli G, Marconi M. Plasma exchange ineffective in amyotrophic lateral sclerosis. Arch Neurol 1980;37: 511-513.
12. McKenna KE, Whittaker S, Rhodes LE, Taylor P, Lloyd J, Ibbotson S, Russell-Jones R. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006;154:7-20.
13. Child FJ, Mitchell TJ, Whittaker SJ, Scarisbrick JJ, Seed FT, Russell-Jones R. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides. Clin Exp Dermatol 2004;29:231-236.
14. Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R, Fraser DD, Dalakas M, Plotz PH. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-1384.
15. Choy EH, Hoogendijk JE, Lecky B, Winer JB. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 2005:CD003643.
16. Zheng X, Sadler JE. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. In: Young NS, Gerson SL, High KA, editors. Clinical Hematology, 1st ed. Philadelphia: Mosby. 2006. pp 802-813.
17. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-1086.
18. Buskard N, Rock G, Nair R. The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group. Transfus Sci 1998;19:295-300.
19. Patel TC, Moore SB, Pineda AA, Witzig TE. Role of plasmapheresis in thrombocytopenic purpura associated with Waldenstrom's macroglobulinemia. Mayo Clin Proc 1996;71:597-600.
20. von Baeyer H. Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience. Ther Apher Dial 2003;7:127-140.
21. Dau PC. Leukocytapheresis in inclusion body myositis. J Clin Apher 1987;3:167-170.
22. Dau PC. Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol 1981;38:544-552.
23. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, Greipp PR, Witzig TE, Basu R, Suarez GA, Fonseca R, Lust JA, Gertz MA. POEMS syndrome: definitions and long-term outcome. Blood 2003;101:2496-2506.
24. Dispenzieri A. POEMS Syndrome. Hematology Am Soc Hematol Educ Program 2005:360-367.
25. Clemmensen OJ, Andresen R, Andersen E. Plasmapheresis in the treatment of psoriasis. A controlled clinical study. J Am Acad Dermatol 1983;8:190-192.
26. Lieden G, Skogh M. Plasma exchange and leukapheresis in psoriasis - no effect? Arch Dermatol Res 1986;278:437-440.
27. Rothwell RS, Davis P, Gordon PA, Dasgupta MK, Johny KV, Russell AS, Percy JS. A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthritis Rheum 1980;23:785-790.
28. Dwosh IL, Giles AR, Ford PM, Pater JL, Anastassiades TP. Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial. N Engl J Med 1983;308:1124-1129.
29. Schulz SC, van Kammen DP, Waters R, Klein HG, Balow JE, Bunney WE, Jr. Double-blind evaluation of plasmapheresis in schizophrenic patients: a pilot study. Artif Organs 1983;7:317-321.
30. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J, Heald PW, Steen V, Massa MC, Murphy GF, Perniciaro C, Istfan M, Ballas SK, Edelson RL. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992;128:337-346.
31. Enomoto DN, Mekkes JR, Bossuyt PM, Yong SL, Out TA, Hoekzema R, de Rie MA, Schellekens PT, ten Berge IJ, de Borgie CA, Bos JD. Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 1999;41:915-922.
32. Knobler RM, French LE, Kim Y, Bisaccia E, Graninger W, Nahavandi H, Strobl FJ, Keystone E, Mehlmauer M, Rook AH, Braverman I. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 2006;54:793-799.
33. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis.The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992;326:1373-1379.
34. Wallace DJ, Goldfinger D, Pepkowitz SH, Fichman M, Metzger AL, Schroeder JO, Euler HH. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis. J Clin Apher 1998;13:163-166.
35. Danieli MG, Palmieri C, Salvi A, Refe MC, Strusi AS, Danieli G. Synchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. J Clin Apher 2002;17:72-77.